Your browser doesn't support javascript.
loading
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.
Drögemöller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen E B; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin J D; Gelmon, Karen A; Carleton, Bruce C.
Afiliación
  • Drögemöller BI; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Monzon JG; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Bhavsar AP; Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Borrie AE; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Brooks B; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Wright GEB; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Liu G; Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Renouf DJ; Audiology and Speech Pathology Department, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Kollmannsberger CK; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Bedard PL; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Aminkeng F; Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre - University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Amstutz U; BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada.
  • Hildebrand CA; BC Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada.
  • Gunaretnam EP; Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.
  • Critchley C; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Chen Z; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Brunham LR; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Hayden MR; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ross CJD; University Institute of Clinical Chemistry, Inselspital Bern University Hospital and University of Bern, Bern, Switzerland.
  • Gelmon KA; Pharmaceutical Outcomes Programme, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Carleton BC; BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
JAMA Oncol ; 3(11): 1558-1562, 2017 Nov 01.
Article en En | MEDLINE | ID: mdl-28448657
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Cisplatino / Transportadores de Ácidos Monocarboxílicos / Variantes Farmacogenómicas / Pérdida Auditiva / Antineoplásicos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: JAMA Oncol Año: 2017 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Cisplatino / Transportadores de Ácidos Monocarboxílicos / Variantes Farmacogenómicas / Pérdida Auditiva / Antineoplásicos Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: JAMA Oncol Año: 2017 Tipo del documento: Article País de afiliación: Canadá